CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in AGIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,969,930
+$3,831,938 QoQ
Shares Held
538,128
+12.8% QoQ
Ownership
0.901%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. AGIO ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in AGIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,969,930 | 538,128 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,137,992 | 477,032 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,136,970 | 482,622 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,354,946 | 482,186 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $15,833,123 | 476,041 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,623,269 | 464,958 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $15,527,894 | 472,547 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $20,687,496 | 465,620 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,728,564 | 457,527 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,872,383 | 440,232 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $10,163,894 | 456,394 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $11,179,451 | 451,695 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $12,383,628 | 437,275 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $9,872,781 | 429,812 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,068,082 | 429,775 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $11,893,521 | 420,563 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,681,461 | 391,586 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,505,669 | 395,248 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,675,822 | 385,635 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $18,949,236 | 410,601 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $20,694,135 | 375,506 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,300,510 | 276,927 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $11,553,121 | 266,631 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,214,275 | 263,265 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,862,198 | 277,902 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $8,888,201 | 250,513 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||